Cromos Pharma Recruits over 300 Patients in Under Two Months into a COVID-19 Clinical Trial June 18, 2020 – Portland, OR. Cromos Pharma, an international CRO, is pleased to announce unprecedented recruitment in a phase IIb trial in patients with moderate to severe COVID-19 infection. It has successfully recruited over 300 patients in under two months to the trial. “We are very proud of our team for this fantastic accomplishment,”
Cromos Pharma insights on master protocols We are delighted to share with you the just published article that provides an overview of master protocols written by Cromos Pharma’s CEO, Dr Vlad Bogin. Master protocols are disrupting the clinical trial space by offering a more comprehensive and adaptive approach to studying treatments for the most complex of diseases. This paper was submitted
Cromos Pharma celebrates International Clinical Trials Day 2020 On International Clinical Trials Day 2020, we take time out to recognize the immense efforts of those who participate in and conduct clinical research. Clinical Trials Day was established to commemorate the day that James Lind began the first randomized clinical trial in 1747. It gives the industry and research professionals an opportunity to share the
